ארא-סל 4 גרם - Ara-cell 4 g

×©××× ××Â !
××ª×¨××¤× × ×¢××× ×:××××¨ ××ª×¨××¤××ª ×©× ××©×¨× ×××¨××××ª.
×× ××ª×§××× ××××¢× ×¢× ××¤×¡×§×ª ×©××××§ ××ª×¨××¤× ×:××¢×¨××ª ×××××¢××ª ×¢× ××¤×¡×§×ª ×©××××§ ×ª×¨××¤××ª.
×ª××¨×× ×¢×××× ×××¨×× ××ª×¨××¤× ×× ××××§××ª×¨××¤××ª ××× 14/05/19.

× ×ª×× × ×ª×¨××¤×

×××¨×©×

××× ×× ×× × ××¡×¤××	××¨×-×¡× 5 ××¨× - Ara-cell 5 g
×§×××¦× ×¤×¨××§××××××ª (ATC4)	L01BC Pyrimidine analogues
××¨××× ×¤×¢×× (ATC5)	Â Cytarabine 4000MG / 80 ML âL01BC01
×¦××¨×ª ××ª×	×ª××-××¨××× - I.V
×¦××¨×ª ××× ××	×ª×××¡× ×××× ×¤××××, SOLUTION FOR INFUSION ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	ARA-cellÂ® 4000 mg is indicated for induction and maintenance of clinical remission in patients with acute myeloid leukemia, acute non-lymphoblastic leukemias, acute lymphoblastic leukemias, blast crises of chronic myeloid leukemia, diffuse histiocytic lymphomas (non-Hodgkin's lymphomas of high malignancy).
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	××× ×¢××× ××¨××¤× Â

×¢××× ××¦×¨××	Â

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
[ ××¨×-×¡× 4 ××¨×] ×××××¨ ××©×¨× ×××¨××××ª

השינוי האחרון נעשה בֹ־2 בינואר 2022 ב־08:19

ויקיתרופות